Apple Inc. (NASDAQ: AAPL) has now reported its quarterly earnings report, which was also the end of the technology giant’s fiscal year as well. Earnings came in at $8.26 per share (EPS) on sales of $37.5 billion. Estimates were down to $7.93 EPS from $8.67 EPS a year ago. Revenue was expected to be $36.84 billion, which would have been 2.4% sales growth from a year ago.
Apple’s quarterly net income was $7.5 billion. Gross margin came in about 37%. Apple had previous offered up guidance for this quarter of 36% to 37% margins on sales of $34 billion to $37 billion.
Tim Cook gave guidance of $55 billion to $58 billion in revenue this coming quarter versus estimates of $55.65 billion. The guidance was also shown in a range of 36.5 percent and 37.5 percent for gross margin. Apple’s cash, cash equivalents, and securities added up to almost $147 billion at the end of the September quarter.
International sales accounted for 60% of revenue in this last quarter. Unit sales were as follows:
Top 5 Long Term Companies To Watch In Right Now: Unum Group(UNM)
Unum Group, together with its subsidiaries, provides group and individual disability insurance products primarily in the United States and the United Kingdom. It also provides a portfolio of other insurance products, including employer-and employee-paid group benefits, life insurance, long-term care insurance, and related services. Its products include group long-term and short-term disability; group life and accidental death, and dismemberment; individual disability; group long-term care; voluntary benefits; group life; accident, sickness, and disability; and cancer and critical illness insurance products. The company also provides individual life and corporate-owned life insurance, reinsurance pools and management operations, group pension, health insurance, and individual annuities. Unum Group markets its products primarily to employers interested in providing benefits to their employees. The company sells its products through field sales personnel, independent brokers, consultants, and agency sales force. Unum Group was founded in 1848 and is based in Chattanooga, Tennessee.
Advisors' Opinion:- [By Ben Levisohn]
Among the biggest losers in the S&P 500: Air Products and Chemicals (APD), which dropped 3.3% to $103.20 as its Bill Ackman bounce fades, Charles Schwab (SCHW), which fell 2.4% to $21.76 as it became the 165th most popular short in the S&P 500, and Unum Group (UNM), which finished off 2.3% at $29.63 after Barron’s Sandra Ward recommended investors take profits on the insurance company.
- [By Rich Duprey]
Specialty insurance provider�Unum (NYSE: UNM ) announced yesterday its third-quarter dividend of $0.145 per share, an 11% increase to the payout made last quarter of $0.13 per share.
Top 10 Integrated Utility Stocks To Buy For 2014: Catalyst Pharmaceutical Partners Inc.(CPRX)
Catalyst Pharmaceutical Partners, Inc., a development-stage biopharmaceutical company, focuses on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy. It is evaluating its lead product candidate, CPP-109, a GABA aminotransferase inhibitor candidate, which is under Phase II(b) clinical trial for the treatment of cocaine addiction, as well as focuses on evaluating CPP-109 for the treatment of other addictions and obsessive-compulsive disorders. The company is also developing CPP-115, a GABA aminotransferase inhibitor for various indications, including drug addiction, epilepsy, and for other selected central nervous disease indications. It has license agreements with Brookhaven Science Associates, LLC on various patents and patent applications relating to the use of vigabatrin as a treatment for cocaine and other addictions, and obsessive-compulsive disorders; and with Northwestern University to commercialize GABA aminotransferase inhibitors worldwide, as well as a definitive clinical trial agreement with the National Institute on Drug Abuse to jointly conduct a U.S. Phase II(b) clinical trial evaluating CPP-109 for the treatment of cocaine addiction. Catalyst Pharmaceutical Partners, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 biopharmaceutical player that's starting to move within range of triggering a big breakout trade is Catalyst Pharmaceutical Partners (CPRX), which is focused on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy. This stock has been on fire so far in 2013, with shares up a whopping 364%.
If you take a look at the chart for Catalyst Pharmaceutical Partners, you'll notice that this stock has been uptrending strong for the last month, with shares soaring higher from its low of $1.29 to its intraday high of $2.09 a share. During that uptrend, shares of CPRX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed share of CPRX within range of triggering a big breakout trade.
Traders should now look for long-biased trades in CPRX if it manages to break out above its 50-day moving average of $2.11 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 2.21 million shares. If that breakout triggers soon, then CPRX will set up to re-test or possibly take out its next major overhead resistance levels at $2.87 to $3 a share. Any high-volume move above those levels will then give CPRX a chance to re-test its 52-week high at $3.65 a share.
Traders can look to buy CPRX off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $1.65 to $1.63 a share. One can also buy CPRX off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By John Udovich]
While the Twitter IPO has been grabing everyone�� attention, biotech IPOs continue to dominate both biotech and IPO news with Karyopharm Therapeutics Inc (NASDAQ: KPTI) going public yesterday and�Relypsa (NASDAQ: RLYP), TetraLogic Pharmaceuticals (NASDAQ: TLOG), Vital Therapies (NASDAQ: VTL) and Xencor (NASDAQ: XNCR) filing to go public in the near future�(despite the sector producing some�ugly charts�for the month of October) plus�another small cap called TNI BioTech (OTCMKTS: TNIB) has also been producing a steady flow of news:
Karyopharm Therapeutics Debuts. Yesterday, small cap Karyopharm Therapeutics, which is working on a drug that aids the body�� natural tumor-suppressing proteins,�debuted at the top of�its range to raise $109 million in an upsized�offering of 6.8 million shares at $16 apiece with shares closing at $16.81. It should be noted that Karyopharm Therapeutics��lead drug candidate (Selinexor) is in early-stage clinical trials�and the company lost�lost nearly $12.5 million on revenue of $366,000 during the first six months of this year. Biotech IPOs by Region. On an interesting note, Luke Timmerman, the National Biotech Editor of Xconomy, has written a�good�article tracking biotech or life sciences IPOs by region. By his count, Boston is home to eight of the 45 (18%) of the life sciences IPOs this year (its companies have also�raised the most money - about $770 million)�plus�the New York/northern New Jersey region is also home to�eight. San Diego�came in third with six IPOs followed by San Francisco with five while only five of the 45 biotech IPOs�came from outside the�US (Three from Israel and two from Europe). However, the above figures may change as by his account, there are 15 additional biotech companies in line to go public. More Biotechs Set IPO Terms. The small cap biotech space is about to be joined by a few new additions as a couple of biotechs file to go public�over the past�week or so: Relypsa, which is d - [By Paul Ausick]
Stocks on the move: Catalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) is up about 40% at $1.98 after its firdapse drug treatment for certain kinds of muscle weakness was designated a breakthrough therapy by the FDA. Food maker Dean Foods Inc. (NYSE: DF) held a 1-for-2 reverse stock split this morning and the shares are up about 95%, as might be expected.
- [By Roberto Pedone]
Catalyst Pharmaceutical Partners (CPRX) is focused on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy. This stock closed flat to $1.87 in Tuesday's trading session.
Tuesday's Range: $1.78-$1.98
52-Week Range: $0.41-$3.65
Tuesday's Volume: 1.62 million
Three-Month Average Volume: 2.20 millionFrom a technical perspective, CPRX closed off its intraday low of $1.78 to $1.87 with lighter-than-average volume. This stock has been uptrending for the last few weeks, with shares moving higher from its low of $1.29 to its recent high of $2.07. During that move, shares of CPRX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CPRX within range of triggering a near-term breakout trade. That trade will hit if CPRX manages to take out some near-term overhead resistance levels at $2.07 to its 50-day moving average of $2.16 with high volume.
Traders should now look for long-biased trades in CPRX as long as it's trending above some near-term support at $1.63 and then once it sustains a move or close above those breakout levels with volume that's near or above 2.20 million shares. If that breakout hits soon, then CPRX will set up to re-test or possibly take out its next major overhead resistance levels at $2.87 to $3. Any high-volume move above those levels will then give CPRX a chance to re-test its 52-week high at $3.65.
Top 10 Integrated Utility Stocks To Buy For 2014: Brazilian Real(BK)
The Bank of New York Mellon Corporation, a financial services company, provides various products and services worldwide. The company offers a range of equity, fixed income, cash, and alternative/overlay products, as well as distributes investment management products. It also provides investment management, wealth and estate planning, and private banking solutions to high-net-worth individuals and families, charitable gift programs, endowments and foundations, and related entities, as well as offers mutual funds, separate accounts, and annuities. In addition, the company provides global custody and fund, securities lending, investment manager outsourcing, performance and risk analytics, alternative investment, securities clearance, collateral management, corporate trust, broker-dealer, and employee investment plan services, as well as clearing services and global payment/working capital solutions to institutional clients. Further, it offers American and global depositary re ceipt programs, cash management solutions, payment services, liquidity services, foreign exchange, global clearing and execution, managed account services, and global prime brokerage solutions to corporations, public funds, government agencies, foundations, and endowments; global financial institutions, including banks, broker-dealers, asset managers, insurance companies and central banks; and financial intermediaries, independent registered investment advisors, and hedge fund managers. Additionally, the company provides credit-related services, and global markets and institutional banking services; engages in business exits, and corporate treasury activities; and leases financing portfolios. The Bank of New York Mellon Corporation was founded in 1784 and is headquartered in New York, New York.
Advisors' Opinion:- [By Amanda Alix]
These objectors to the $8.5 billion settlement decided to take this suggestion to heart, sending a letter to settlement trustee Bank of New York Mellon (NYSE: BK ) , requesting that they and Bank of America sit down and talk. B of A's response? A resounding "No."
Top 10 Integrated Utility Stocks To Buy For 2014: Piedmont Natural Gas Company Inc.(PNY)
Piedmont Natural Gas Company, Inc., an energy services company, engages in the distribution of natural gas to residential, commercial, industrial, and power generation customers in portions of North Carolina, South Carolina, and Tennessee. It also operates energy-related businesses, including unregulated retail natural gas marketing, regulated interstate natural gas storage, and intrastate natural gas transportation. The company serves approximately 1 million customers, including 51,800 customers served by municipalities. Piedmont Natural Gas Company, Inc. was founded in 1949 and is headquartered in Charlotte, North Carolina.
Advisors' Opinion:- [By Rick Munarriz]
Tuesday
Piedmont Natural Gas (NYSE: PNY ) hopes to energize investors with its quarterly report on Tuesday. The utility company distributes natural gas to more than a million customers in North Carolina, South Carolina, and Tennessee. The stock's 3.7% yield may not seem high, but slow and steady growth should give Piedmont the ability to increase that payout over time. - [By Steven Russolillo]
WATCH FOR:�May ADP Jobs Survey (8:15 a.m. Eastern Time): seen +210K; previously +220K. April US Trade Deficit (8:30): seen $40.9B; previously $40.4B. First Quarter Productivity (8:30, second read): seen -3.1%; previously -1.7%. First Quarter Unit Labor Costs (8:30, second read): seen +5.5%: previously +4.2%. May ISM Non-Manufacturing PMI (10:00): seen 55.2; previously 55.2. Analogic(ALOG), Ciena(CIEN), Cooper, Diamond Foods(DMND), J.M. Smucker(SJM), Joy Global(JOY), Piedmont Natural Gas(PNY), UTi Worldwide, Vail Resorts, Vera Bradley(VRA) and VeriFone(PAY) are among companies scheduled to report quarterly results.
- [By Seth Jayson]
Piedmont Natural Gas (NYSE: PNY ) reported earnings on June 7. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended April 30 (Q2), Piedmont Natural Gas crushed expectations on revenues and met expectations on earnings per share.
Top 10 Integrated Utility Stocks To Buy For 2014: Mackinac Financial Corporation(MFNC)
Mackinac Financial Corporation operates as the holding company for mBank that engages in commercial banking business. It offers interest bearing and non-interest bearing deposit products, including commercial and retail checking accounts, negotiable order of withdrawal accounts, money market accounts, individual retirement accounts, regular interest-bearing statement savings accounts, and certificates of deposit. The company?s loan portfolio comprises commercial real estate loans; commercial, financial, and agricultural loans; one-to-four family residential real estate loans; construction loans; and consumer loans. It operates 6 branch offices in the Upper Peninsula of Michigan, and 4 branch offices in Michigan?s Lower Peninsula; and also operates 10 automated teller machines. The company was founded in 1974 and is headquartered in Manistique, Michigan.
Advisors' Opinion:- [By Marc Bastow]
Michigan-based bank holding company Mackinac Financial (MFNC) raised its quarterly dividend 25% to 5 cents per share, payable on Jan. 8 to shareholders of record as of Dec. 30.
MFNC Dividend Yield: 2.1%
Top 10 Integrated Utility Stocks To Buy For 2014: Werner Enterprises Inc (WERN)
Werner Enterprises, Inc., incorporated on September 14, 1982, is a transportation and logistics company engaged primarily in hauling truckload shipments of general commodities in both interstate and intrastate commerce. The Company also provides logistics services through its value added services (VAS) division. As of the year ended December 31, 2012, the Company had a fleet of 7,150 trucks, of which 6,505 were Company-operated and 645 were owned and operated by independent contractors. The Company operates in two segments: Truckload Transportation Services (Truckload) and VAS.
Truckload segment
The Company's Truckload segment consists of the One-Way Truckload and Specialized Services units. One-Way Truckload includes the operating fleets: the regional short-haul (Regional) fleet transports a variety of consumer nondurable products and other commodities in truckload quantities within geographic regions across the United States using dry van trailers; the medium-to-long-haul van (Van) fleet provides comparable truckload van service over irregular routes, and the expedited (Expedited) fleet provides time-sensitive truckload services utilizing driver teams.
Specialized Services provides truckload services dedicated to a specific customer, generally for a retail distribution center or manufacturing facility, including services for products requiring specialized trailers such as flatbed or temperature-controlled trailers. The Company's Truckload fleets operate throughout the 48 contiguous United States, both common and contract, granted by the United States Department of Transportation (DOT). The Company also has authority to operate in several provinces of Canada and to provide through-trailer service into and out of Mexico. The principal types of freight the Company transports include retail store merchandise, consumer products, grocery products and manufactured products. The Company focuses on transporting consumer nondurable products that generally ship.
!
VAS segment
The Company's VAS segment is a non-asset-based transportation and logistics provider. VAS is consists of four operating units that provide non-trucking services to the Company's customers: truck brokerage (Brokerage) uses contracted carriers to complete customer shipments; freight management (Freight Management) offers a range of single-source logistics management services and solutions; the intermodal (Intermodal) unit offers rail transportation through alliances with rail and drayage providers as an alternative to truck transportation, and Werner Global Logistics international (WGL) provides complete management of global shipments from origin to destination using a combination of air, ocean, truck and rail transportation modes. The Company's Brokerage unit had transportation services contracts with approximately 9,400 carriers as of December 31, 2012.
Advisors' Opinion:- [By Seth Jayson]
Werner Enterprises (Nasdaq: WERN ) reported earnings on July 22. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), Werner Enterprises missed estimates on revenues and missed estimates on earnings per share.
Top 10 Integrated Utility Stocks To Buy For 2014: Embraer-Empresa Brasileira de Aeronautica(ERJ)
Embraer S.A. engages in the development, production, and sale of jet and turboprop aircraft for civil and defense aviation markets. It also offers aircrafts for agricultural use; structural components, mechanical and hydraulic systems, and technical activities related to the production and maintenance of aerospace material. The company?s Commercial Aviation segment designs, develops, and manufactures various commercial aircraft for regional, low-cost, and mainline airlines primarily in Europe, the Middle East, Africa, Asia, and the Americas. Its Defense and Security segment provides a range of integrated solutions for the defense and security market, including training/light attack aircraft, aerial surveillance platforms, military transport aircraft, and government transport aircraft; command, control, communications, computer, intelligence, surveillance, and reconnaissance systems; and maintenance and material solutions. The company?s Executive Aviation segment develops a line of executive jets for fractional ownership companies, charter companies and air-taxi companies, and high-net-worth individuals. Its Aviation Services segment offers after-sales customer support services for the fleets of its commercial, executive, and defense customers. This segment also provides spare parts, maintenance and repair, training, and other product support services. The company?s Other segment involves in selling and leasing used aircraft; and offers structural parts, and mechanical and hydraulic systems for the production of helicopters. This segment also manufactures landing gear, and general aviation propeller aircraft, such as executive planes and crop dusters. It has a strategic alliance with European Aerospace and Defense Group. The company was formerly known as Embraer - Empresa Brasileira de Aeron Advisors' Opinion:
- [By Ben Levisohn]
Boeing has risen 4.2% to $127.65 today, while jet maker Embraer (ERJ) has advanced 2.4% to $33.77 and BAE System (BAESY) has dropped 0.4%. Lockheed Martin (LMT) has ticked up 0.5% to $130.67 and Northrop Grumman (NOC) has jumped 3.7% to $105.25.
- [By Alex Planes]
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown. The best stocks offer sustainable market-beating gains, with robust and improving financial metrics that support strong price growth. Does Embraer (NYSE: ERJ ) fit the bill? Let's take a look at what its recent results tell us about its potential for future gains.
No comments:
Post a Comment